Related Experiment Video
Updated: Jul 15, 2026
07:21
Systems Analysis of the Neuroinflammatory and Hemodynamic Response to Traumatic Brain Injury
Published on: May 27, 2022
Blood-Based Mechanistic Biomarkers Improve Prognostication of Functional Outcome After Mild Traumatic Brain Injury
Koen Visser1, Myrthe E de Koning2, Bram Jacobs1
1Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Journal of Neurotrauma
|July 14, 2026
Summary
Blood biomarkers, including interleukin-6 and tryptophan, modestly improve predictions of incomplete functional recovery after mild traumatic brain injury (mTBI). Further research into these mechanistic markers is needed for better mTBI prognosis.
Area of Science:
- Neuroscience
- Biochemistry
- Clinical Medicine
Background:
- Prognostic models for mild traumatic brain injury (mTBI) recovery have modest performance.
- Blood-based biomarkers may enhance the accuracy of these predictions.
- Established and novel mechanistic biomarkers reflecting pathophysiological processes are under investigation.
Purpose of the Study:
- To evaluate the incremental value of mechanistic biomarkers (interleukin-6, -8, -10, free thiols, tryptophan) in predicting incomplete functional recovery after mTBI.
- To compare the prognostic performance of these novel markers against established mTBI biomarkers (GFAP, UCH-L1, NFL).
- To assess biomarker performance in enhancing existing clinical prognostic models.
Main Methods:
- A prospective longitudinal cohort study (Acute Injury Markers for mild traumatic brain injury) enrolled 257 mTBI patients.
- Blood samples were collected within 24 hours and 4-6 weeks post-injury.
- Prognostic models were built using emergency department (ED) data and ED data plus symptom questionnaires (ED+), with Glasgow Outcome Scale Extended (GOS-E) at 6 months as the primary outcome.
Main Results:
- Plasma interleukin-6 (IL-6) was the only individual biomarker to modestly improve the ED model's predictive performance.
- Combining IL-6 with tryptophan showed the largest improvement for the ED model.
- The combination of IL-6, tryptophan, and free thiols improved the ED+ model's performance, although individual biomarkers showed negligible improvement.
Conclusions:
- Blood-based mechanistic markers, particularly IL-6, offer marginal improvements to prognostic models for mTBI functional recovery.
- Further investigation of these markers, especially IL-6, is warranted for refining mTBI prognosis.
- The study underscores the potential of specific biomarkers in predicting long-term outcomes after mild traumatic brain injury.
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:28Traumatic Brain Injury l: Introduction
DefinitionTraumatic brain injury, or TBI, is a disturbance of normal brain function induced by an external mechanical force, such as a direct blow to the head or a penetrating injury. It can affect both brain structure and function, producing a wide range of clinical outcomes. TBI is a heterogeneous condition, meaning its effects may differ based on the type, location, and severity of the injury.Basis of ClassificationTBI is classified based on severity, injury mechanism, or pathophysiology. In...